Mutation and association analysis of the DAP-1 gene with schizophrenia

Psychiatry Clin Neurosci. 2003 Oct;57(5):545-7. doi: 10.1046/j.1440-1819.2003.01162.x.

Abstract

Glutamate dysfunction has been hypothesized to be involved in the pathophysiology of schizophrenia. The human homolog of Drosophila discs large protein (hDLG) and post-synaptic density-95-associated protein-1 (DAP-1) is one of the major proteins that are involved in intracellular signal transduction via N-methyl-d-aspartate receptors. In the present study 33 Japanese patients with schizophrenia were screened for mutations in the DAP-1 gene. A single nucleotide polymorphism was identified in the DAP-1 gene (1618A/G). A case-control study using a larger sample of unrelated patients and controls did not reveal a significant association between this polymorphism and schizophrenia. The results do not provide evidence that the DAP-1 gene is involved in vulnerability to schizophrenia.

MeSH terms

  • Case-Control Studies
  • DNA / genetics*
  • DNA Mutational Analysis
  • Female
  • Gene Frequency
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Nerve Tissue Proteins / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Single-Stranded Conformational
  • SAP90-PSD95 Associated Proteins
  • Schizophrenia / genetics*

Substances

  • DLGAP1 protein, human
  • Nerve Tissue Proteins
  • SAP90-PSD95 Associated Proteins
  • DNA